An international study proves that the combination of simvastatin and rifaximin is not effective in patients with decompensated cirrhosis
An international study proves that the combination of simvastatin and rifaximin is not effective in patients with decompensated cirrhosis https://www.tauli.cat/institut/wp-content/uploads/2025/03/Estudi-cirrosi-hepatica-1200x675.jpeg 1080 608 Mireia Córcoles https://www.tauli.cat/institut/wp-content/uploads/2022/11/Tezza-0184-150x150.jpg
A group of researchers from I3PT has collaborated on an important European study whose results have been published in the prestigious journal JAMA
read more